Delivery Order SPE2DB22D3016-SPE2DB26FABR1
Award Date 11/7/25
Potential Completion Date 12/2/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg tablets (28-count package) under a firm fixed-price contract. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a non-competitive delivery order with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count package), with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed from the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (quantity 28) on September 24, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $15,151.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 280 mg tablets (28 count) on June 6, 2025, with completion targeted for June 30, 2025. This non-competitive, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,151.52 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count units) on September 8, 2025, with an ultimate completion date of September 29, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $15,967.36 delivery order to AmerisourceBergen Drug Corp for 28-tablet containers of Imbruvica 420 mg on October 27, 2025, with completion scheduled for November 18, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive procurement under the company's broader pharmaceutical supply relationship with the federal government. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count units) valued at $53,030.25 with a firm fixed price structure. The order is scheduled for completion by September 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract and is issued under...
- The Defense Logistics Agency awarded a $15,151.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Imbruvica 420 mg tablets (28-count units). The contract, which is a non-set-aside competitive award, is scheduled for completion by October 17, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count) with a ceiling value of $76,839.82. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count packaging) under a firm fixed price contract type. The delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...